Photocure announces regulatory approval of Hexvix in Chile
STOCKHOLM, Aug. 16, 2021 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that the Marketing Authorization for Hexvix® in Chile has been granted. Photocure’s partner and exclusive distributor, Genotests SpA, received the official…
